The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Matthew Barcus is an analyst at Chardan Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/29/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/26/2025 | ZURA | Buy Now | Zura Bio | $1.36 | 635.29% | Matthew Barcus55% | $12 → $10 | Maintains | Buy | Get Alert |
| 11/08/2024 | ZURA | Buy Now | Zura Bio | $1.36 | 782.35% | Matthew Barcus55% | $14 → $12 | Maintains | Buy | Get Alert |
| 06/22/2023 | QURE | Buy Now | uniQure | $12.47 | 116.52% | Matthew Barcus55% | $45 → $27 | Maintains | Buy | Get Alert |
| 06/14/2023 | ZURA | Buy Now | Zura Bio | $1.36 | 929.41% | Matthew Barcus55% | → $14 | Initiates | → Buy | Get Alert |
| 05/30/2023 | XLO | Buy Now | Xilio Therapeutics | $0.71 | 885.5% | Matthew Barcus55% | → $7 | Reiterates | Buy → Buy | Get Alert |
| 05/23/2023 | IMVT | Buy Now | Immunovant | $18.35 | 74.39% | Matthew Barcus55% | $21 → $32 | Maintains | Buy | Get Alert |
| 05/17/2023 | PPBT | Buy Now | Purple Biotech | $2.72 | 304.19% | Matthew Barcus55% | → $220 | Reiterates | Buy → Buy | Get Alert |
| 05/16/2023 | QURE | Buy Now | uniQure | $12.47 | 260.87% | Matthew Barcus55% | $56 → $45 | Maintains | Buy | Get Alert |
| 05/12/2023 | FIXX | Buy Now | Homology Medicines | — | — | Matthew Barcus55% | $144 → $126 | Maintains | Buy | Get Alert |
| 05/11/2023 | XLO | Buy Now | Xilio Therapeutics | $0.71 | 885.5% | Matthew Barcus55% | → $7 | Reiterates | → Buy | Get Alert |
| 04/18/2023 | ANIX | Buy Now | Anixa Biosciences | $3.15 | 185.71% | Matthew Barcus55% | → $9 | Reiterates | → Buy | Get Alert |
| 03/28/2023 | AMTI | Buy Now | Applied Molecular | — | — | Matthew Barcus55% | — | Downgrade | Buy → Neutral | Get Alert |
| 03/22/2023 | ANIX | Buy Now | Anixa Biosciences | $3.15 | 185.71% | Matthew Barcus55% | $8 → $9 | Maintains | Buy | Get Alert |
| 03/17/2023 | IMNM | Buy Now | Immunome | $6.99 | 14.45% | Matthew Barcus55% | $9 → $8 | Maintains | Buy | Get Alert |
| 03/06/2023 | AMTI | Buy Now | Applied Molecular | — | — | Matthew Barcus55% | → $3 | Reiterates | → Buy | Get Alert |
| 02/28/2023 | QURE | Buy Now | uniQure | $12.47 | 381.15% | Matthew Barcus55% | → $60 | Reiterates | → Buy | Get Alert |
| 02/09/2023 | PPBT | Buy Now | Purple Biotech | $2.72 | 304.19% | Matthew Barcus55% | → $220 | Reiterates | → Buy | Get Alert |
| 02/06/2023 | IMVT | Buy Now | Immunovant | $18.35 | 14.44% | Matthew Barcus55% | $19 → $21 | Maintains | Buy | Get Alert |
| 12/23/2022 | ANIX | Buy Now | Anixa Biosciences | $3.15 | 153.97% | Matthew Barcus55% | → $8 | Initiates | → Buy | Get Alert |
| 12/21/2022 | XLO | Buy Now | Xilio Therapeutics | $0.71 | 885.5% | Matthew Barcus55% | → $7 | Initiates | → Buy | Get Alert |
| 12/02/2022 | AMTI | Buy Now | Applied Molecular | — | — | Matthew Barcus55% | → $3 | Initiates | → Buy | Get Alert |
| 12/01/2022 | ONCR | Buy Now | Oncorus | — | — | Matthew Barcus55% | — | Downgrade | Buy → Neutral | Get Alert |
| 11/17/2022 | VINC | Buy Now | Vincerx Pharma | $0.55 | 445.45% | Matthew Barcus55% | $80 → $60 | Maintains | Buy | Get Alert |
| 11/17/2022 | FIXX | Buy Now | Homology Medicines | — | — | Matthew Barcus55% | $180 → $144 | Maintains | Buy | Get Alert |
| 11/07/2022 | IMVT | Buy Now | Immunovant | $18.35 | 3.54% | Matthew Barcus55% | $12 → $19 | Maintains | Buy | Get Alert |
| 09/29/2022 | IMVT | Buy Now | Immunovant | $18.35 | -34.6% | Matthew Barcus55% | $14 → $12 | Maintains | Buy | Get Alert |
| 09/08/2022 | PPBT | Buy Now | Purple Biotech | $2.72 | 304.19% | Matthew Barcus55% | → $220 | Initiates | → Buy | Get Alert |
| 08/16/2022 | FIXX | Buy Now | Homology Medicines | — | — | Matthew Barcus55% | $252 → $180 | Maintains | Buy | Get Alert |
| 08/09/2022 | QURE | Buy Now | uniQure | $12.47 | 381.15% | Matthew Barcus55% | $65 → $60 | Maintains | Buy | Get Alert |
| 07/21/2022 | VBLT | Buy Now | Vascular Biogenics | — | — | Matthew Barcus55% | — | Downgrade | Buy → Neutral | Get Alert |
| 06/15/2022 | ONCR | Buy Now | Oncorus | — | — | Matthew Barcus55% | → $5 | Initiates | → Buy | Get Alert |
| 06/07/2022 | VINC | Buy Now | Vincerx Pharma | $0.55 | 627.27% | Matthew Barcus55% | $220 → $80 | Maintains | Buy | Get Alert |
| 05/13/2022 | VINC | Buy Now | Vincerx Pharma | $0.55 | 1900% | Matthew Barcus55% | $280 → $220 | Maintains | Buy | Get Alert |
| 04/28/2022 | VBLT | Buy Now | Vascular Biogenics | — | — | Matthew Barcus55% | → $175 | Initiates | → Buy | Get Alert |
| 03/09/2018 | VBLT | Buy Now | Vascular Biogenics | — | — | Matthew Barcus55% | — | Downgrade | Buy → Neutral | Get Alert |
| 09/21/2015 | VBLT | Buy Now | Vascular Biogenics | — | — | Matthew Barcus55% | → $875 | Initiates | → Buy | Get Alert |
